How to Help Your Patients Save Money on Pitavastatin: A Provider's Guide to Savings Programs

Pitavastatin offers meaningful clinical advantages for specific patient populations — but its cost can create a significant access barrier. With retail prices ranging from $330 to $440+ per month and most insurance formularies excluding it, providers who understand the savings landscape can make a direct difference in whether their patients can afford continuous statin therapy. This guide covers every cost-reduction strategy available in 2026.

Why Pitavastatin Cost Management Matters Clinically

Statin therapy requires long-term adherence to be effective. Gaps in treatment — even brief ones — are clinically meaningful. For high-risk cardiovascular patients, several studies have associated statin discontinuation with increased major adverse cardiovascular events. For patients with familial hypercholesterolemia, consistency is even more critical given the magnitude of baseline LDL elevation.

When pitavastatin is the clinically appropriate choice, cost barriers that cause patients to skip doses or abandon therapy represent a preventable clinical harm. Integrating cost management into your prescribing workflow — not just as an afterthought — protects outcomes.

The Cost Landscape: What Patients Actually Pay

Understanding what patients face helps you counsel them accurately:

• Retail price (no assistance): $330–$445/month for generic; $444–$945+ for brand Livalo
• Commercial insurance: Typically not covered or placed on high tier; patients often pay full retail
• Medicare Part D: Most plans do not include pitavastatin on formulary; manufacturer savings cards do not apply to Medicare patients
• GoodRx / coupon price: $36–$47/month for generic pitavastatin (dramatic reduction from retail)
• Livalo Savings Program: As low as $25/month for eligible commercially insured or cash-paying patients on brand Livalo

Strategy 1: The Livalo Manufacturer Savings Program

For patients on brand-name Livalo, Kowa Pharmaceuticals America offers a savings program that can reduce the monthly cost to as little as $25 for eligible patients. This is typically the lowest-cost option for commercially insured or uninsured patients who are prescribed brand Livalo specifically.

Eligibility criteria: Commercially insured patients or cash-paying patients. Does NOT apply to Medicare, Medicaid, or government-funded insurance programs. The program covers both 30- and 90-day supplies.

How to access: Call 844-567-9504. Patients can also be directed to the program online. Consider prescribing brand Livalo with a DAW (dispense as written) notation for eligible patients who will enroll in this program, as the savings may make the brand cost lower than the generic with a coupon.

Strategy 2: GoodRx and Third-Party Discount Cards for Generic Pitavastatin

For patients on generic pitavastatin (or Medicare patients who cannot access the Livalo Savings Program), GoodRx and SingleCare provide substantial savings. Both services are free to use for patients and provide digital coupons accepted at most retail pharmacies.

• GoodRx: Generic pitavastatin as low as $36–$47/month (2 mg, 30 tablets). Accepted at 70,000+ pharmacies nationwide.
• SingleCare: Generic pitavastatin as low as ~$39/month. Similar coverage to GoodRx.

Provider tip: Instruct patients to use coupons instead of their insurance card when picking up pitavastatin, as the coupon price is typically lower than insurance copays for this non-formulary drug. The pharmacy can process whichever is cheaper.

39,049+ patients found their medications in stock

39K+

Find Pitavastatin In Stock Today →

Strategy 3: Prior Authorization for Commercial Insurance

When you have a clinical rationale for pitavastatin over formulary alternatives, a prior authorization request is worth pursuing. Well-documented PA requests significantly increase approval rates. Key documentation elements:

• CYP3A4 drug interactions: Document specific medications the patient takes that interact with formulary statins (atorvastatin, simvastatin) via CYP3A4, and note that pitavastatin avoids these interactions.
• Glycemic concerns: For patients with T2DM or prediabetes, cite clinical evidence that pitavastatin has a more favorable effect on HbA1c and fasting glucose compared to covered statins.
• HIV/ART compatibility: Document the patient's antiretroviral regimen and the reduced interaction risk with pitavastatin compared to formulary alternatives.
• Trial and failure: If the plan requires step therapy, document previous attempts with covered statins (atorvastatin, rosuvastatin) and why those were not tolerated or are not appropriate.

Strategy 4: Mail-Order and Online Pharmacies

Direct patients to mail-order and online pharmacy options, which often offer lower prices and more reliable supply for less-common drugs like pitavastatin:

• Cost Plus Drugs: Transparent pricing model. Check costplusdrugs.com for current pitavastatin pricing.
• Amazon Pharmacy: Accepts GoodRx coupons; 2-day shipping to most locations.
• Insurance mail-order benefit: If the plan covers pitavastatin at any tier, a 90-day mail-order fill is typically cheaper per dose than 30-day retail fills.

Skip the calls, skip the stress.

Find Pitavastatin In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Strategy 5: When to Consider a Formulary Alternative

For some patients, the cost barrier cannot be overcome — particularly Medicare patients who cannot access manufacturer savings cards and for whom the GoodRx price ($36-$47/month) is still prohibitive. In these cases, a formulary alternative may be clinically appropriate:

• Pravastatin: The most favorable glycemic profile among widely available alternatives; no CYP metabolism; well-studied in HIV patients. As low as $4-$10/month.
• Rosuvastatin: Minimal CYP metabolism (CYP2C9); strong LDL lowering; generic as low as $2-$15/month. Somewhat higher diabetes risk than pitavastatin.
• Atorvastatin: Generic available at $4-$15/month; may not be appropriate if CYP3A4 interactions are the reason for pitavastatin.

Supporting Patients With Pharmacy Access and Affordability

When cost concerns interact with pharmacy availability issues, patients face a compounding access challenge. Direct patients to medfinder for providers to help locate nearby pharmacies with pitavastatin in stock. Combined with the savings strategies above, this addresses both dimensions of the access problem.

Related reading: Pitavastatin Availability: What Providers and Prescribers Need to Know in 2026